» Articles » PMID: 29300770

Oxytocin is Lower in African American Men with Diabetes and Associates with Psycho-social and Metabolic Health Factors

Overview
Journal PLoS One
Date 2018 Jan 5
PMID 29300770
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Recently, it has been suggested that oxytocin (OT) has a role in metabolism and neuropsychiatry health and disease, and therefore, it may represent a potential therapeutic target. The current study aimed to investigate relationships between OT and glycemic status along with psycho-social and behavioral factors.

Design And Methods: A total of 92 obese or overweight, African American, male subjects were enrolled in the study. Biometric and biochemical data were collected including oral glucose tolerance testing and urinary OT (measured by ELISA). Subjects also completed questionnaires on social and lifestyle factors.

Results: OT levels were found to be significantly lower in subjects with type 2 diabetes mellitus (T2DM) compared to normal glucose tolerance (p<0.05). When stratified by OT tertiles, subjects with higher OT had lower weight, body mass index (BMI) and hemoglobin A1c, but higher eGFR which remained significant after BMI adjustment. The highest OT tertile also had more smokers and more users of psychiatric medications. A stepwise ordered logistic regression supported these findings and could account for 21% of the variation in OT categories (pseudoR2 = 0.21).

Conclusions: In this unique population, OT was found lower in subjects with diabetes but higher with better renal function, cigarette smoking and use of psychiatric medications. Future studies are needed to confirm these findings and examine the potential therapeutic role of OT.

Citing Articles

Systems Biology of Human Microbiome for the Prediction of Personal Glycaemic Response.

Kirtipal N, Seo Y, Son J, Lee S Diabetes Metab J. 2024; 48(5):821-836.

PMID: 39313228 PMC: 11449821. DOI: 10.4093/dmj.2024.0382.


Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity.

Gan H, Cerbone M, Dattani M Endocr Rev. 2023; 45(3):309-342.

PMID: 38019584 PMC: 11074800. DOI: 10.1210/endrev/bnad033.


The Long Way of Oxytocin from the Uterus to the Heart in 70 Years from Its Discovery.

Camerino C Int J Mol Sci. 2023; 24(3).

PMID: 36768879 PMC: 9916674. DOI: 10.3390/ijms24032556.


Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19.

Wang S, Zhang F, Zhu H, Yang H, Liu Y, Wang P Front Endocrinol (Lausanne). 2022; 13:799521.

PMID: 35592777 PMC: 9110836. DOI: 10.3389/fendo.2022.799521.


The Effects of Oxytocin on Appetite Regulation, Food Intake and Metabolism in Humans.

Kerem L, Lawson E Int J Mol Sci. 2021; 22(14).

PMID: 34299356 PMC: 8306733. DOI: 10.3390/ijms22147737.


References
1.
Ogden C, Carroll M, Kit B, Flegal K . Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012; 307(5):483-90. PMC: 6362452. DOI: 10.1001/jama.2012.40. View

2.
Matta S, Foster C, Sharp B . Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. Endocrinology. 1993; 132(5):2149-56. DOI: 10.1210/endo.132.5.8386611. View

3.
Ziegler T, Scheffler G, Snowdon C . The relationship of cortisol levels to social environment and reproductive functioning in female cotton-top tamarins, Saguinus oedipus. Horm Behav. 1995; 29(3):407-24. DOI: 10.1006/hbeh.1995.1028. View

4.
Lawson E, Marengi D, DeSanti R, Holmes T, Schoenfeld D, Tolley C . Oxytocin reduces caloric intake in men. Obesity (Silver Spring). 2015; 23(5):950-6. PMC: 4414748. DOI: 10.1002/oby.21069. View

5.
Barengolts E . OXYTOCIN - AN EMERGING TREATMENT FOR OBESITY AND DYSGLYCEMIA: REVIEW OF RANDOMIZED CONTROLLED TRIALS AND COHORT STUDIES. Endocr Pract. 2016; 22(7):885-94. DOI: 10.4158/EP151192.RA. View